Multisystem manifestations in myotonic dystrophy type 1 (DM1) may be due to dosage reduction in multiple genes induced by aberrant expansion of CTG repeats in DMPK, including Dmpk and its neighboring genes (Six5 or Dmwd) and downstream Mbnl1. However, the direct evidences are lack. Here, we develop a new strategy to generate mice carrying multigene 5 mutations in one step by injection of haploid embryonic stem cells with mutant Dmpk, Six5 and Mbnl1 into oocytes. The triple heterozygous mutant mice exhibit adult-onset DM1 phenotypes.
Introduction
Myotonic Dystrophy type 1 (DM1) is a complex disease with variable pathological phenotypes, disease severity, and onset ages [1] [2] [3] . The major symptoms include myotonia, muscle wasting, muscle weakness, cardiac conduction defects, cataracts and insulin resistance [3] . DM1 is a genetic disease caused by the expansion of a CTG repeat in the 3'-untranslated region of the 5 dystrophia myotonica protein kinase (Dmpk) gene [4] [5] [6] . Usually, with an increasing number of the repeats, respiratory failure and mental retardation can be observed in the most severe congenital form of the disease (congenital DM1, CDM) [7] [8] [9] [10] . A large amount of studies have shown that the triple repeat expansion not only reduces the protein or mRNA levels of Dmpk [11] [12] [13] , but also alters the adjacent chromatin structure and reduces the expression of the 10 neighboring genes [14] [15] [16] [17] , including downstream Six5 [18] [19] [20] [21] [22] in DM1 cells or patients, albeit existence of controversy observations [24] [25] [26] . Moreover, numerous studies have also shown nuclear accumulation of RNA containing the expanded CUG repeats aberrantly recruits splicing regulators, such as Mbnl1, and forms the ribonuclear aggregates (foci) in nucleus, leading to misregulation of alternative splicing [27] [28] [29] [30] [31] [32] . Mouse models carrying 15 mutations in Dmpk, could only partially recapitulate the multisystem manifestations of DM1 patients [3] . Furthermore, the defects could only be observed in homozygous mutant mice (the affected proteins were totally absent), while the affected proteins were indeed present with a decreased level in human patients. Another set of DM1 mouse models are generated by overexpression of the toxic CTG repeats [38] , however, they could not 20 fully recapitulate human phenotypes, either [38] . As an example, though the transgenic model carrying human skeletal actin (HSA) gene to express ~250 untranslated CUG repeats in the muscle (HSA LR ) can recapitulate multiple muscle phenotypes associated with DM1, it doesn't exhibit other common DM1-related symptoms, such as muscle wasting and cataract [39] . Meanwhile, this model cannot mimic CDM symptoms [39] . The potential reason might be that 25 the random insertion of transgenes in chromatin does not affect the expression of Dmwd-Dmpk-Six5 locus, which may be also involved in the complex symptoms of DM1 [39] . Taken together, mouse DM1 models that better recapitulate the varieties of human symptoms are required to fully understand the underlying mechanism of DM1.
The multisystem symptoms of DM1 may be caused by the combination of different 30 mechanisms, leading to down-regulation of multiple genes, including Dmwd-Dmpk-Six5 and Mbnl1 [40, 41] . However, the direct evidence to support the notion is missing due to the challenges to generate mice carrying multiple gene mutations simultaneously. It is time and labor consuming to generate mice carrying triple or quadruple mutations using conventional methods.
Recently, mouse androgenetic haploid embryonic stem cells (AG-haESCs) have been successfully developed as sperm replacement to efficiently produce semi-cloned (SC) animals by 5 injection into oocytes (intracytoplasmic AG-haESC injection, ICAHCI) [42] [43] [44] . AG-haESCs enable one-step efficient and stable generation of mice with multiple heterozygous mutant genes by ICAHCI of haploid cells carrying these mutations [42] , allowing production of sufficient numbers of SC offspring for analyses in one generation. Thus, the haploid ESC-mediated SC technology may provide us an ideal tool to generate mouse models with multiple heterozygous 10 mutant genes in one step to mimic the reduced expression of multiple genes in human complex diseases.
In this study, we tested our hypothesis by generating triple and quadruple heterozygous mutant mice in one step through injection of haploid ESCs (O48 cell line used in this study) carrying triple or quadruple mutant genes (Dmpk, Six5 and Mbnl1 or Dmpk, Six5, Mbnl1 and Dmwd) into 15 oocytes. Mice with triple mutations exhibited most of the major pathogenic phenotypes observed in adult-onset DM1 patients. Mice with quadruple mutations could mimic symptoms of patients from the most severe form of DM1, congenital DM1 (CDM). Interestingly, differentiation of muscle stem cells (MuSCs) is defective in both models due to stemness reduction, which recapitulates the defects in human DM1 patients and provides a novel system for screening of 20 drugs to treat muscle problems in DM1 in the future.
Results

Generation of a novel DM1 model carrying mutations in Dmpk, Six5 and Mbnl1
We first examined the feasibility of SC technology to generate mouse models of DM1 carrying single mutant gene by injection of haploid cells carrying mutation in Dmpk, Six5 or Mbnl1, the three well-studied DM1-related genes. A haploid cell line (termed H19 △DMR -IG △DMR -AGH or 5 O48) that has been reported to efficiently support SC mice generation [42] was used in this study.
We generated haploid ESC lines carrying mutant Dmpk, Six5 or Mbnl1 (referred to as ΔDmpk-O48, ΔSix5-O48 and ΔMbnl1-O48), respectively (Figure S1, S2 and S3) and found that these cells efficiently supported the generation of live SC pups carrying heterozygous mutant Dmpk, Six5 or Mbnl1 by ICAHCI (Table S1 ). Mutant SC mice grew up normally to adulthood and 10 showed similar growth curves compared to those of wildtype (WT) SC mice produced from O48 (Figure S1, S2 and S3). Histological analysis of adult mice (4-6 month old) showed no obvious phenotypic abnormality in the muscle of Dmpk +/-, Six5 +/or Mbnl1 +/-SC mice (Figure S1, S2 and S3).
We then set out to generate SC mice carrying triple mutations of Dmpk, Six5 and Mbnl1 in one 15 step using ICAHCI. We disrupted Six5 and Mbnl in ΔDmpk-O48-1 cells that have been analyzed as shown in Figure S1 and generated stable haploid cell lines carrying triple knockouts (termed ΔDSM-O48) (Figure 1a and 1b). Whole-genome sequencing analysis showed no off-target effect in ΔDSM-O48-1 cells (Table S2 ). ICAHCI experiments showed that ΔDSM-O48 cells (from two cell lines, i.e., ΔDSM-O48-1 and ΔDSM-O48-2) could reproducibly produce live SC pups 20 (termed DSM-TKO SC mice) after injection into oocytes ( Figure 1b and Table S1 ). Over 90% of DSM-TKO SC pups grew up to adulthood and showed the similar growth profiles as those of WT SC mice ( Figure 1c , S4a and Table S1 ). We then examined muscle phenotypes commonly observed in DM1 patients, including myotonia, muscle weakness and wasting in DSM-TKO SC mice. Electromyography (EMG) tests in skeletal muscle demonstrated myotonia in adult DSM-25 TKO SC mice ( Figure 1d ). Mouse treadmill assay and grip strength test revealed that DSM-TKO SC mice displayed muscle weakness (Figure 1e and 1f); and rotarod test indicated that DMS-TKO SC mice exhibited severe motor defects (Figure 1g ). Histological analysis of tibialis anterior (TA) muscles from DMS-TKO SC mice revealed several main histological hallmarks of muscles from DM1 patients, including increased number of nuclear clump and decreased fiber size (shown as the myofiber cross-sectional area (CSA)), a sign of muscle wasting (Figure 1h and 1i). Meanwhile, consistent with the clinical observations, dystrophin (Dys) expression in DMS-TKO SC mice was normal ( Figure S4b ). Fiber type analysis indicated an increased ratio of type I (slow) myofiber and a decreased CSA of type I in DSM-TKO SC mice ( Figure S4c ).
Abnormalities of diaphragm muscle and small intestine were also observed ( Figure S4d and S4e), 5 implying the potential breathing and digestive dysfunctions in DMS-TKO SC mice. We next analyzed the cardiac structure and function in adult DMS-TKO SC mice because heart abnormalities are common in DM1 patients [45] . Echocardiography did not show obvious structure and functional abnormalities in 4-month-old DMS-TKO SC mice ( Figure S4f and S4g).
However, 12-month-old DMS-TKO SC mice exhibited significantly lower ejection fraction 10 ( Figure S4g ) probably induced by increased myocardial fiber abnormalities in DMS-TKO SC mice ( Figure S4h ).
These data demonstrate that Dmpk +/-; Six5 +/-; Mbnl1 +/-SC mice can be generated in one step using haploid cells carrying triple mutations. DSM-TKO SC mice mimic the reduced dosage of three genes and display more severe pathological consequences compared to DM1 models 15 carrying single homozygous mutant (Table S3) , providing a new model of DM1. However, DSM-TKO SC mice cannot mimic several phenotypes frequently observed in DM1 patients, such as cataracts and symptoms observed in CDM patients, implying that other genes may be involved.
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Dmwd is involved in DM1
It has been shown that the expansion of the CTG repeats in Dmpk produces allele-specific effects on transcription of the two adjacent genes, Six5 (downstream of Dmpk) and Dmwd (upstream of Dmpk) through changes of the local chromatin structure, leading to downregulation of Six5 and Dmwd in DM1 patients [14, 18-21, 23, 46-50] . The effects of Six5 in DM1 25 have been well characterized using Six5 knockout mice [35, 36, 51] ; however, the role of Dmwd in DM1 has not been analyzed yet. We set out to test the function of Dmwd by generating haploid cells carrying mutant Dmwd gene using CRISPR-Cas9 (Figure 2a ) [52] . Ten stable cell lines carrying mutant Dmwd gene (termed ΔDmwd-O48) were obtained (Figure 2b and 2c ). By injecting these cells into oocytes, live SC pups could be efficiently produced ( Figure 2d and Table S1 ). Dmwd +/-SC mice grew up to adulthood normally (Figure 2e and Table S1 ).
Phenotype analysis showed that the myofiber CSA was dramatically reduced in adult Dmwd +/mice ( Figure 2f -i), suggesting that Dmwd is involved in pathological mechanism of DM1. But other symptoms of DM1, such as cardiomyocytes defects and cataracts, cannot be observed in Dmwd +/mice, suggesting that Dmwd is not sufficient to account for all the complex multisystem 5 symptoms of DM1.
Generation of congenital DM1 (CDM) mice carrying quadruple mutations
Next, we tested whether the compound loss of Dmpk, Six5, Mbnl1 and Dmwd could give rise to a mouse model recapitulating the majority of the symptoms in DM1 patients and the more severe 10 CDM manifestations. We further mutated Dmwd gene in ΔDSM-O48-1 cells and generated stable haploid cell lines carrying quadruple mutations (termed ΔDSMD-O48) ( Figure 3a ). Offtarget analysis indicated no unexpected mutant site in tested cells (ΔDSMD-O48-2) (Table S2 ). ICAHCI analysis of three lines (ΔDSMD-O48-1, -2 and -3) generated Dmpk +/-; Six5 +/-; Mbnl1 +/-; Dmwd +/-SC mice (DSMD-QKO SC mice) efficiently (Table S1, Figure S5a and S5b). In contrast 15 to mice carrying the single mutation or triple mutations, around 22% of newborn DSMD-QKO SC pups with normal body weights died in a couple of hours after birth ( Figure 3b ). The autopsy indicated that the lung expansion failure might contribute to the neonatal death of DSMD-QKO SC pups ( Figure S5c ). Lung expansion failure can be caused by dysfunction of diaphragm muscle; we therefore dissected diaphragm from DSMD-QKO SC pups. The results showed 20 obvious pathogenic alterations, including the reduced myofiber CSA and disorganized myofibers in diaphragm (Figure 3c and 3d ). Moreover, immunofluorescent staining analysis showed a significant decrease of the complexity of mature neuromuscular junctions (NMJs) in DSMD-QKO diaphragm muscles ( Figure 3e ). Taken together, these results indicate that our DSMD-QKO SC mouse model recapitulates the postnatal respiratory insufficiency in CDM patients, 25 which is the main cause of neonatal mortality of CDM patients [53] . They also suggest that the postnatal respiratory insufficiency in CDM patients may be due to the defects of diaphragm muscle [54] .
We next characterized the growth profiles of DSMD-QKO SC mice. Interestingly, DSMD-QKO SC pups exhibited growth-retarded phenotype (Figure S5d and S5e) and 46% of them died within 3 weeks postnatally (Table S1 ). We sacrificed DSMD-QKO SC pups at postnatal day 2 (P2) and observed residual milk in their stomach, excluding the possibility that they died of feeding difficulties. P2 pups exhibited overt abnormal intestines ( Figure S5f ), consistent with the gastrointestinal abnormalities observed in CDM patients [53] . Meanwhile, some of the DSMD-QKO SC pups had abnormal talus bone development ( Figure S5f ), recapitulating the 5 distinguishing feature of talipes in CDM patients [55] . Neonatal hypotonia, another typical manifestation of CDM patients [53] , was also observed in DSMD-QKO SC pups ( Figure S5g ), probably due to less muscle fibers in the mutant pups ( Figure 3f ). Cardiac problem is considered to be a common cause of sudden death in patients with DM1 [45, 56] . We then performed echocardiography (ECG) test and found 2 of 7 mice (P17) exhibited ventricular premature beats 10 ( Figure S5h ). Interestingly, these two pups died in a few days after ECG examination.
Histological analysis of the heart showed the ventricular and atrial wall attenuation ( Figure 3g ).
Taken together, DSMD-QKO SC mice represent a novel model that can mimic developmental defects of CDM patients, suggesting that the reduced dosage of multiple genes is responsible for the CDM phenotypes and Dmwd is involved in DM1 symptoms. implying that other genes, such as MBNL2 or CUGBP1 that might be involved in DM1 patients, should be included in our mouse models in future.
Since mis-splicing is a characteristic feature of DM1 and the dosage of Mbln1 is also reduced in our models, we next analyzed splicing profiles of 7 DM1-related genes in P2, P10 and adult mice 10 (4-month old). RT-qPCR analysis demonstrated the misregulation of Ldb3, Serca1, m-TTN, Tmem63b, Sorbs1, and Spag9 mRNA splicing( Figure S8a-b ), while the splicing efficiencies of Dysf were unchanged similar as that in the DM1 patients ( Figure S8c ). In addition, we also checked the splicing of Clcn1, Ryr1, Ryr2, Tnnt2, and Tnnt3 mRNA, and they were showed unchanged in our mouse models (data not shown), reflecting the heterogeneity of mis-splicing in 15 patients [59, 60] and suggesting that other genes may be involved in our models to mimic these splicing abnormalities. Taken together, DSMD-QKO SC mice can recapitulate most of the symptoms in DM1 and CDM (Table S3) , providing another new model for DM1 study. Figure S9a ). We then tested the in vitro proliferation ability of TKO and QKO MuSCs using the long-term expansion protocol established by Fu et al [68] . The results showed that the proliferation abilities of both MuSCs were comparable to that from WT SC mice ( Figure S9b ). We next analyzed the differentiation potentials of TKO and QKO MuSCs by culturing them in differentiation medium as reported previously [68] . The results showed that the fusion index was decreased in myofibers differentiated from both TKO and QKO MuSCs (Figure 5b ). In contrast, MuSCs from a well-established transgenic mouse model expressing long repeat of CUG (HSA LR ), which develops myotonia and myopathy [39], didn't show differentiation defects in vitro ( Figure   5 S9c-e). To further confirm the differentiation defect was cell autonomous, we performed MuSC transplantation experiments. We generated QKO SC mice carrying RFP transgenes (termed RFP-QKO SC mice) and control SC mice carrying EGFP transgene (EGFP-WT SC mice) ( Figure   S10a and S10b) and then obtained MuSCs from the two strains, respectively ( Figure S10c ). Consistent with the above results, RFP-QKO MuSCs showed normal proliferation ability and 10 decreased in vitro differentiation potential ( Figure S10c ). We next transplanted RFP-QKO or EGFP-WT MuSCs to TA muscles of non-fluorescent recipients. The results showed that the CSA of RFP + myofibers (myofibers generated from the transplanted RFP-QKO MuSCs) was significantly smaller than the CSA of the EGFP + myofibers generated from the transplanted EGFP-WT MuSCs (Figure 5c ). Since both types of MuSCs shared the same recipient 15 microenvironment, we conclude that the differentiation defects of QKO MuSCs are cell autonomous. Together, these results demonstrate decreased differentiation potential of MuSCs in TKO and QKO SC mice, mimicking another important symptom in DM1 patients.
Muscle stem cells are defective in DSM-TKO and DSMD-QKO SC mice
We next attempted to reveal the underlying mechanisms by comparing the genome-wide gene expression profiles of MuSCs (Day 0) and differentiating cells (Day 1 and Day 2) between 20 mutant and normal SC mice ( Figure S11a ). Clustering analysis indicated that cells with the same differentiation stage rather than with the same genotype exhibited higher correlation ( Figure   S11b ), suggesting that TKO and QKO mutations do not dramatically change the cell fate.
Interestingly, the total number of differentially expressed genes (DEGs) between mutant cells and WT cells dramatically decreased after induction of differentiation (Figure 5d ), implying that 25 the major differences existed at the stem cell stage. Enrichment analysis of DEGs on Day 0 showed that muscle differentiation-related genes (such as muscle development and contraction) were up-regulated in mutant MuSCs compared to WT cells (Figure 5e and S11c-S11e). In contrast, the expression levels of stem cell markers were similar (Figure 5e and S11d-S11e).
Nevertheless, qRT-PCR analyses indicated that the expression levels of the muscle-30 differentiation-related genes were comparable in differentiating cells from mutant and wild-type MuSCs ( Figure S11f ). These results demonstrate that MuSCs of TKO and QKO SC mice are at a more committed state [69] . The premature expression of differentiation genes at stem cell stage suggests the partial loss of stemness and may account for the decreased differentiation potential of mutant MuSCs in vitro and in vivo.
Discussion
Mutations or expression changes occur in multiple genes in most of the diseases, especially in those multisystem syndromes. Generation of mouse models carrying multigene mutations to faithfully recapitulate the complex symptoms is the key to elucidate the mechanism of these syndromes. However, it is time consuming and labor intensive to do so using the conventional 5 methods, leading to the lack of proper animal models for many syndromes. In this proof-ofconcept study, we generated mouse models to mimic the reduced expression of multiple genes in human DM1 in one step by ICAHCI of haploid ESCs carrying three or four mutant genes. Dmwd is also affected (mimicked by DSMD-QKO SC mice), leading to more severe and early onset DM1 (Table S3 ). The longer the CTG repeat expansion is, the expression of more genes may be affected. Interestingly, MuSC stemness is affected in our DM1 mouse models, consistent with the observations in both DM1 and CDM patients [61, 63, 70] and recent observations in homozygous mice carrying Mbnl3 gene depletion [26] . Taken together, our study provides the 25 direct evidence to support the hypothesis that expansion of the CTG repeats affects the expression level of multiple genes, leading to complex pathogenic phenotypes in DM1 patients.
Meanwhile, TKO and QKO mouse models may provide a novel platform for drug screening to treat DM1.
Our method paves the road towards generating a series of mouse models carrying multiple gene 30 mutations in a short time to mimic different stages and severity of the complex syndromes. A 13 potential application of the approach is to produce mice carrying multiple modifications in candidate loci that have been identified in high-throughput studies or genetic screenings to mimic clinical manifestations of multigenic diseases. In summary, we have established novel DM1 mouse models by one-step injection of haploid cells carrying three or four mutant genes into oocytes, providing suitable models to investigate the molecular mechanisms underlying 5 complex manifestations and perform drug screening. Future analysis of the TKO and OKO mice will reveal more genes involved in the complex manifestations of DM1. Meanwhile, we hope that our haploid ESC-mediated SC technology will promote modeling of other complex diseases in mice.
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Materials and Methods
Experimental mice
All animal procedures were carried out in accordance with the guidelines of the Shanghai Institute of Biochemistry and Cell Biology (SIBCB). All mice were housed in specific pathogenfree facilities of SIBCB. Oocytes for micromanipulation were obtained from female mice of 5 B6D2F1 (C57BL/6 × DBA/2) background. HSA LR mice (FVB/n background) and IL2r −/− mice (C57BL/6 background) were purchased from the Jackson Laboratory.
Derivation of gene-modified haploid cell lines
CRISPR-Cas9-mediated Gene manipulation was performed as previously described methods [52, 
Immunostaining
Dissected tissues from diaphragm, heart and tibialis anterior (TA) muscle were put into the OCT (Leica) directly, and then frozen in liquid nitrogen for 15 s. The frozen tissues could be stored in -80°C refrigerators until sectioning. For whole heart longitudinal sections, the fresh dissected tissues were washed with PBS and fixed with 4% paraformaldehyde (PFA) at 4°C for 30 min.
After dehydrated with 30% sucrose solution, the samples were embedded in OCT. The protocol 5 for Pax7 (DHSB, 1:200) staining was carried out according to previously described protocols [68, 73] . The immunostaining for dystrophin was perform using anti-dystrophin (abcam, ab15277) as primary antibody (1:400) 
Grip strength, treadmill, rotarod test and righting assay
The forelimb grip strength of mice (4-month-old) was assessed using a grip strength meter.
Every mouse was tested for five times and the arithmetic average value of the records shall be as the measured value. For treadmill test, following familiarization test (6 m/min for 3 min), the mouse (4-month-old) was placed on a treadmill with a start speed of 10 m/min. Running speed 30 was increased by 2 m/min every two minutes until 30 m/min, and the distance was recorded when the mouse could no longer run. For rotarod performance test, the mouse (4-month-old) was placed on a rotating rod at uniform motion (10 rpm) for 5 min and then an accelerating rotarod, which started with 4 rpm and gradually increased to 40 rpm in 5 minutes. The mice were pretrained for 2 days for adaptation. The duration time on the rotarod before the mice fell off was recorded. As for righting assay, the mice at P5 were placed on its back to determine if the mice 5 could right themselves to normal posture with four paws on the ground.
MuSC isolation, expansion and in vitro differentiation
MuSCs were isolated according to previously described methods [67, 68, 75] 
MuSC transplantation (in vivo differentiation)
MuSC transplantation was performed according to described protocols [76, 77] with some modifications. Briefly, both hindlimbs of host IL2r −/− mice were exposed to 18 Gy gamma radiations. Twenty-four hours before MuSC transplantation, 10 μM CTX (15 μl) is intramuscularly injected into mouse TA muscle via a 29 G insulin syringe. 5 x 10 5 MuSCs were 20 resuspended with 30 μl of PBS and injected into TA muscle using 29 G insulin syringe. TA muscles were collected in 4 weeks after cell transplantation and used for histological analysis.
EdU labeling
MuSCs were cultured in MuSC medium with EdU solution (Invitrogen, final concentration, 10 25 μM) for 2 h at 37 °C, followed by fixation with 3.7% PFA, permealized with 0.5% Triton X-100, reacted with Click-iT reaction cocktail and counterstained with Hoechst 33342.
Skeletal preparation and staining
Skeletal preparations were stained with alcian blue and ARS. Briefly, the mice were executed, 30 eviscerated and skinned. The samples were dehydrated with 95% ethanol for 3 days, and then were stained in Alcian blue solution for 3 days. After fixed and cleared with 95% ethanol for three times ( 
Western blotting
Dissected tissues were frozen with liquid nitrogen and stored in -80°C refrigerators until protein extraction. The homogenization of the tissue was done by vortex in cell lysis buffer. After 20 separated on SDS-PAGE gels, the lysate was transferred to PVDF membranes and incubated with primary antibodies (anti-Mbnl1, abcam, ab108519; anti-SIX5, abcam, ab113064; anti-DMWD, santa cruz, sc-167638; anti-DMPK, santa cruz, sc-13612) at 4°C overnight, followed by incubation with secondary antibodies.
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RNA-seq and gene expression analysis
MuSCs (Day 0) and differentiating cells (Day 1 an Day 2) were collected and referred to RNA extraction using TRIZOL Reagent (Invitrogen). The total RNA was processed for RNA-seq by and RNase-Free DNase Set (QIAGEN). Adaptors as well as low quality base pairs were trimmed.
The sequencing was performed using Illumina Hiseq X TEN and then the preprocessed reads were aligned to the protein-encoding gene of mouse reference genome (NCBI Mus musculus assembly GRCm38.p5) using hisat2 (version 2.0.5). Transcriptome profiling was determined in units of RPKM (Reads Per Kilobase per Million mapped reads) using locally developed Perl 5 script.
Quantitative RT-PCR analysis
Total RNA was extracted from dissected tissues according to the manufacturer's instructions. 0.5 μg of total RNA was reverse transcribed using a First Strand cDNA Synthesis kit (TOYOBO). 10 qPCR was carried out with THUNDERBIRD SYBR qPCR Mix (Toyobo) on a CFX connect Real-Time System (BIO-RAD). Q-PCR primers were listed in Table S3 . For alternative splicing analysis, the primers, which could separate the splice alternatives of target genes [78] , were used to amplify the RNA variants, followed by running on 2% agarose gel or SDS-PAGE to calculate the splicing efficiency (percent of spliced in).
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Statistical analysis
Quantitative values are presented mean ± s.e.m, unless noted otherwise. Statistical differences between groups were determined by using GraphPad Prism 6 using unpaired two-tailed t-test. No statistical method was used to predetermine sample size. Investigators were not blinded to 20 outcome assessment.
Accession number
All RNA-seq data sets are available through GEO under the accession number GEO: GSE103841. DSM-TKO SC mice, n = 7). Unpaired Student's t test, *P < 0.05. Scale bars, 50 μm.
(i) TA muscles myofiber cross-sectional area (CSA) analysis (n = 3 per group). 
